This chapter argues two evidence-based conclusions: not only are psychiatric drugs
dramatically overprescribed and overvalued but the harms they unleash completely …

" Dr. Paris has written an honest, balanced presentation of the ways in which psychiatric
drugs are evaluated and prescribed. He highlights the complexity of the task, the limits of …

Since the 1950s we have had the same three neurotransmitters to work with to treat
depression, one transmitter for psychoses, three for anxiety. We have developed newer …

The rapid growth in sales of psychotropic medications during the late 1980s and 1990s,
eventually reaching $20 billion/year, reflected the increased use of seritonin reuptake …

Dr. Lagomasino and Dr. Simpson are editors of this column and are affiliated with the
department of psychiatry and behavioral sciences at the University of Southern California …

The effective treatment of many mental health conditions necessitates that clinicians
prescribe medications. Considerations for ethical treatment, however, demand that clinicians …

This paper examines the nature and types of information and syntheses relevant to the
strategic and tactical decisions required in the treatment of depression with medication …

Four background issues are important in understanding the policy debate surrounding new
drugs for psychiatric care. These are the impact of scientific progress, society's nonrational …

Despite the lack of guidance available for practitioners, extensive polypharmacy has
become the primary method of treating patients with severe and chronic mood, anxiety …

When first published in 1999, Your Drug May Be Your Problem was ahead of its time. The
only book to provide an uncensored description of the dangers involved in taking every kind …